Masimo Corporation (MASI) Expected to Announce Earnings of $0.61 Per Share
Analysts forecast that Masimo Corporation (NASDAQ:MASI) will post earnings per share of $0.61 for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Masimo Corporation’s earnings, with estimates ranging from $0.60 to $0.62. Masimo Corporation reported earnings of $0.51 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 19.6%. The firm is expected to report its next earnings report on Tuesday, February 13th.
According to Zacks, analysts expect that Masimo Corporation will report full year earnings of $2.95 per share for the current financial year, with EPS estimates ranging from $2.95 to $2.96. For the next financial year, analysts forecast that the business will post earnings of $2.60 per share, with EPS estimates ranging from $2.48 to $2.75. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Masimo Corporation.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.17. The company had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. Masimo Corporation’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.52 EPS.
In other Masimo Corporation news, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total transaction of $959,750.00. Following the transaction, the director now owns 72,249 shares in the company, valued at approximately $6,303,725.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares in the company, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders sold a total of 39,976 shares of company stock worth $3,559,074 in the last 90 days. 13.10% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MASI. Fortaleza Asset Management Inc. acquired a new position in Masimo Corporation during the 2nd quarter worth approximately $106,000. Dubuque Bank & Trust Co. increased its position in Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after purchasing an additional 61 shares during the period. DekaBank Deutsche Girozentrale increased its position in Masimo Corporation by 78.3% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after purchasing an additional 925 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Masimo Corporation by 13.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock worth $184,000 after purchasing an additional 236 shares during the period. Finally, Campbell & CO Investment Adviser LLC acquired a new position in Masimo Corporation during the 2nd quarter worth approximately $203,000. Institutional investors own 84.94% of the company’s stock.
Shares of Masimo Corporation (NASDAQ MASI) opened at $86.43 on Wednesday. The stock has a market capitalization of $4,469.04, a PE ratio of 33.14, a price-to-earnings-growth ratio of 2.91 and a beta of 0.75. Masimo Corporation has a fifty-two week low of $60.03 and a fifty-two week high of $104.71.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.